FERI (Luxembourg) S.A.’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.5M Buy
12,540
+2,760
+28% +$3.26M 1.94% 9
2026
Q2
$11.7M Buy
+9,780
New +$10M 1.87% 9
2024
Q4
– Sell
-3,230
Closed -$2.86M – 128
2024
Q3
$2.86M Buy
+3,230
New +$2.9M 1.63% 9
2024
Q2
– Sell
-1,150
Closed -$895K – 112
2024
Q1
$895K Sell
1,150
-1,570
-58% -$1.12M 0.63% 63
2023
Q4
$1.59M Buy
+2,720
New +$1.59M 1.17% 21

Other funds holding LLY

FERI (Luxembourg) S.A.'s LLY Position: Q3 2026 in Review

FERI (Luxembourg) S.A. increased its Eli Lilly (LLY) stake by 28% in Q3 2026, buying an estimated $3.26M and bringing the position to 12,540 shares worth $14.5M. The position accounts for 1.94% of the portfolio, ranked #9.

FERI (Luxembourg) S.A. first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. 4,383 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • FERI (Luxembourg) S.A. held 12,540 shares of Eli Lilly worth $14.5M as of Q3 2026.
  • FERI (Luxembourg) S.A. bought 2,760 Eli Lilly shares in Q3 2026, an estimated $3.26M.
  • Eli Lilly made up 1.94% of FERI (Luxembourg) S.A.'s portfolio in Q3 2026, its #9 holding.
  • FERI (Luxembourg) S.A. first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
  • 4,383 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on FERI (Luxembourg) S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.